受强制性开放获取政策约束的文章 - Pedro Pérez Segura了解详情
无法在其他位置公开访问的文章：6 篇
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial
C Balana, R De Las Penas, JM Sepúlveda, MJ Gil-Gil, R Luque, ...
Journal of neuro-oncology 127, 569-579, 2016
强制性开放获取政策： Government of Spain
A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families
A Romero, P Pérez-Segura, A Tosar, JÁ García-Saenz, E Diaz-Rubio, ...
Breast cancer research and treatment 129, 939-946, 2011
强制性开放获取政策： Government of Spain
Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers
J Zugazagoitia, P Pérez-Segura, A Manzano, I Blanco, A Vega, ...
Breast cancer research and treatment 148, 415-421, 2014
强制性开放获取政策： Government of Spain
Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the …
G Ruiz de Garibay, S Gutiérrez-Enríquez, P Garre, S Bonache, A Romero, ...
Breast cancer research and treatment 133, 273-283, 2012
强制性开放获取政策： Government of Spain
Evidence for a link between TNFRSF11A and risk of breast cancer
N Bonifaci, M Palafox, P Pellegrini, A Osorio, J Benitez, P Peterlongo, ...
Breast cancer research and treatment 129, 947-954, 2011
强制性开放获取政策： Government of Spain
BRCA2 gene mutations and coagulation-associated biomarkers
P Perez-Segura, JJ Zamorano-León, D Acosta, JM Santos-Sancho, ...
Thrombosis and Haemostasis 115 (02), 415-423, 2016
强制性开放获取政策： Government of Spain
可在其他位置公开访问的文章：67 篇
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
EEW Cohen, D Soulières, C Le Tourneau, J Dinis, L Licitra, MJ Ahn, ...
The Lancet 393 (10167), 156-167, 2019
强制性开放获取政策： National Institute of Health and Medical Research, France, National …
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
强制性开放获取政策： US National Institutes of Health, National Health and Medical Research …
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores
J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ...
Journal of Clinical Oncology 35 (20), 2240-2250, 2017
强制性开放获取政策： US National Institutes of Health, Research Foundation (Flanders), Natural …
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
V Silvestri, D Barrowdale, AM Mulligan, SL Neuhausen, S Fox, BY Karlan, ...
Breast Cancer Research 18, 1-13, 2016
强制性开放获取政策： US National Institutes of Health, National Health and Medical Research …
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
MT Parsons, E Tudini, H Li, E Hahnen, B Wappenschmidt, L Feliubadaló, ...
Human mutation 40 (9), 1557-1578, 2019
强制性开放获取政策： US Department of Defense, US National Institutes of Health, National Health …
BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers
HD Meeks, H Song, K Michailidou, MK Bolla, J Dennis, Q Wang, ...
Journal of the National Cancer Institute 108 (2), djv315, 2016
强制性开放获取政策： US National Institutes of Health, National Health and Medical Research …
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)
C Balana, MA Vaz, J Manuel Sepúlveda, C Mesia, S Del Barco, E Pineda, ...
Neuro-oncology 22 (12), 1851-1861, 2020
强制性开放获取政策： Government of Spain
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
A Blanco, M de la Hoya, J Balmana, T Ramón y Cajal, A Teulé, ...
Breast cancer research and treatment 132, 307-315, 2012
强制性开放获取政策： Government of Spain
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a …
A Psyrri, J Fayette, K Harrington, M Gillison, MJ Ahn, S Takahashi, ...
Annals of Oncology 34 (3), 262-274, 2023
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
DG Cox, J Simard, D Sinnett, Y Hamdi, P Soucy, M Ouimet, L Barjhoux, ...
Human molecular genetics 20 (23), 4732-4747, 2011
强制性开放获取政策： US National Institutes of Health, Canadian Institutes of Health Research …
Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
A Blanco, M de la Hoya, A Osorio, O Diez, MD Miramar, M Infante, ...
PLoS One 8 (7), e67538, 2013
强制性开放获取政策： Government of Spain
Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants: results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA)
V Silvestri, G Leslie, DR Barnes, BA Agnarsson, K Aittomäki, E Alducci, ...
JAMA oncology 6 (8), 1218-1230, 2020
强制性开放获取政策： US National Institutes of Health, National Health and Medical Research …
Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis
D Subira, C Serrano, S Castanon, R Gonzalo, J Illan, J Pardo, ...
Neuro-oncology 14 (1), 43-52, 2012
强制性开放获取政策： Government of Spain
Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors
PP Segura, M Gil, C Balañá, I Chacón, JM Langa, M Martín, J Bruna
Journal of neuro-oncology 109, 137-142, 2012
强制性开放获取政策： Government of Spain
出版信息和资助信息由计算机程序自动确定